+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Carrier Screening Market Size, Share & Trends Analysis Report By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), By Medical Condition, By Technology, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • December 2022
  • Region: Global
  • Grand View Research
  • ID: 5712512
The global carrier screening market size is expected to reach USD 2.86 billion by 2030 and expand at a CAGR of 12.4% from 2023 to 2030. The increase in technological advancement in carrier screening along with the rising adoption of in vitro fertilization in emerging markets is expected to boost the market growth during the forecast period. The carrier receives the abnormal gene from the parents. Disorders such as sickle cell anemia, cystic fibrosis, Tay-Sachs disease, fragile X syndrome, and SMA can be identified using carrier screening.

Molecular tests are performed to detect the mutation by finding the abnormalities in the DNA. Next-generation sequencing is one of the techniques to perform tests. There is the possibility of the carrier not showing any symptoms and signs of illness. The test is recommended for pregnant women to check whether the baby will have a chance of genetic deformities. It is also advised to the male parent of the child to undergo the carrier screening test. The early-stage disease diagnosis and restraint of these genetic deformities is expected to augment the market growth. The test involves the tissue cells of the cheeks, blood, or saliva samples.

The adoption of carrier screening in the precision medicine market is also increasing. According to the article published in November 2022, by The Medical Journal of Australia, stated that the rapid innovations in genomic medicine along with sequencing technology for genetic code created a lucrative opportunity for genetic carrier screening. For incorporating population screening into precision medicine, a framework such as RE-AIM can be employed to plan research, assess barriers, and evaluates the result. This strategy was employed to assess the population DNA screening in the U.S.

The growing strategic initiatives by hospitals and regulatory bodies to increase the accessibility of carrier screening are expected to support market growth. For instance, in June 2022, NHS announced the expansion of BRCA genetic testing for the Jewish community. Since, 1 in 40 Jews is reported to be the carrier of BRCA, which increases the probability of certain cancers. Similarly, in June 2022, UnitedHealthcare Community proposed to introduce a coverage program for Ashkenazi Jewish Carrier Screening in the U.S.

On the other hand, limited implementation of public health screening, lack of genomic knowledge for reproductive health and primary care, and cost of genomic tests in the emerging market are expected to hamper the market growth. In India, the cost of carrier genetic screening ranges from USD 218 to USD 290. Considering the average purchasing power in the region, the cost is high for the majority of the population.

Carrier Screening Market Report Highlights

  • By type, the expanded carrier screening segment is projected to establish the fastest growth rate over the forecast period. Since increasing product development by the existing players to expand the usage of screening in various fields, such as precision medicine and IVF.
  • By medical condition, the Cystic fibrosis segment is anticipated to have a significant growth rate with a considerable market share in 2022. Owing to the increase in the disease incidence rate and carrier frequency. The product development by the players is likely to support the growth of the segment.
  • By technology, the DNA sequencing segment is anticipated to have the fastest-growing CAGR between 2023 and 2030. The adoption of NGS technology for prenatal diagnostics is considered to be the key driver.
  • By end-user, the laboratory segment is projected to have a majority of the market share in 2022. This is attributed to the presence of well-equipped facilities in developed countries, along with the increasing tests in the rural areas of emerging markets.
  • North America has strengthened its regional position in the market with 40.19% of the overall market share. This is attributed to the presence of hospitals and reference labs, along with the existence of key players in the region.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Carrier Screening Market

What is the estimated value of the Global Carrier Screening Market?

The Global Carrier Screening Market was estimated to be valued at $1263.5 Million in 2023.

What is the growth rate of the Global Carrier Screening Market?

The growth rate of the Global Carrier Screening Market is 12.4%, with an estimated value of $2860 Million by 2030.

What is the forecasted size of the Global Carrier Screening Market?

The Global Carrier Screening Market is estimated to be worth $2860 Million by 2030.

Who are the key companies in the Global Carrier Screening Market?

Key companies in the Global Carrier Screening Market include Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Cepheid, Laboratory Corporation of America Holdings, Otogenetics, Illumina Inc., MedGenome, GeneTech and F. Hoffman.

Table of Contents

Chapter 1 Research Methodology
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region-Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Carrier Screening Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing adoption of IVF and cryopreservation
3.2.2 Technology advancement in screening techniques
3.2.3 Rising awareness in the emerging market
3.3 Market Restraint Analysis
3.3.1 Limited implementation of public health screening
3.4 Carrier screening - SWOT Analysis, By Factor (political & legal, economic, and technological)
3.5 Industry Analysis - Porter’s
3.6 Carrier Screening Market: Market Position Analysis, 2022
3.7 COVID-19 Impact Analysis
Chapter 4 Carrier Screening Market: Type Estimates & Trend Analysis
4.1 Carrier screening Market: Type Movement Analysis
4.2 Expanded carrier screening
4.2.1 Expanded carrier screening market
4.3 Targeted disease carrier screening
4.3.1 Targeted disease carrier screening market
Chapter 5 Carrier Screening Market: Medical Conditions Estimates & Trend Analysis
5.1 Carrier Screening Market: Medical Conditions Movement Analysis
5.2 Cystic fibrosis
5.2.1 Cystic fibrosis market
5.3 Tay-Sachs
5.3.1 Tay-Sachs market
5.4 Gaucher disease
5.4.1 Gaucher disease market
5.5 Sickle cell disease
5.5.1 Sickle cell disease market
5.6 Spinal muscular atrophy
5.6.1 Spinal muscular atrophy market
5.7 Other
5.7.1 Other market
Chapter 6 Carrier screening Market: Technology Estimates & Trend Analysis
6.1 Carrier screening Market: Technology Movement Analysis
6.2 DNA sequencing
6.2.1 DNA sequencing market
6.3 Polymerase chain reaction
6.3.1 Polymerase chain reaction market
6.4 Microarrays
6.4.1 Microarrays market
6.5 Other
6.5.1 Other market
Chapter 7 Carrier screening Market: End-user Estimates & Trend Analysis
7.1 Carrier screening Market: End-user Movement Analysis
7.2 Hospitals
7.2.1 Hospitals market
7.3 Laboratories
7.3.1 Laboratories market
7.4 Physician offices & clinics
7.4.1 Physician offices & clinics market
7.5 Other
7.5.1 Other market
Chapter 8 Carrier screening Market: Regional Estimates & Trend Analysis, by Type, Medical Condition, Technology, End-user
8.1 Carrier Screening Market Share By Region, 2022 & 2030
8.2 North America
8.2.1 SWOT Analysis
8.2.1.1 North America carrier screening market, by type
8.2.1.2 North America carrier screening market, by medical condition
8.2.1.3 North America carrier screening market, by technology
8.2.1.4 North America carrier screening market, by end-user
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Target Disease Prevalence
8.2.2.3 Competitive Scenario
8.2.2.4 Regulatory Framework
8.2.2.5 Reimbursement Scenario
8.2.2.6 U.S. carrier screening market, by type
8.2.2.7 U.S. carrier screening market, by medical condition
8.2.2.8 U.S. carrier screening market, by technology
8.2.2.9 U.S. carrier screening market, by end-user
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Target Disease Prevalence
8.2.3.3 Competitive Scenario
8.2.3.4 Regulatory Framework
8.2.3.5 Reimbursement Scenario
8.2.3.6 Canada carrier screening market, by type
8.2.3.7 Canada carrier screening market, by medical condition
8.2.3.8 Canada carrier screening market, by technology
8.2.3.9 Canada carrier screening market, by end-user
8.3 Europe
8.3.1 SWOT Analysis
8.3.1.1 Europe carrier screening market, by type
8.3.1.2 Europe carrier screening market, by medical condition
8.3.1.3 Europe carrier screening market, by technology
8.3.1.4 Europe carrier screening market, by end-user
8.3.2 Germany
8.3.2.1 Key Country Dynamics
8.3.2.2 Target Disease Prevalence
8.3.2.3 Competitive Scenario
8.3.2.4 Regulatory Framework
8.3.2.5 Reimbursement Scenario
8.3.2.6 Germany carrier screening market, by type
8.3.2.7 Germany carrier screening market, by medical condition
8.3.2.8 Germany carrier screening market, by technology
8.3.2.9 Germany carrier screening market, by end-user
8.3.3 U.K.
8.3.3.1 Key Country Dynamics
8.3.3.2 Target Disease Prevalence
8.3.3.3 Competitive Scenario
8.3.3.4 Regulatory Framework
8.3.3.5 Reimbursement Scenario
8.3.3.6 U.K. carrier screening market, by type
8.3.3.7 U.K. carrier screening market, by medical condition
8.3.3.8 U.K. carrier screening market, by technology
8.3.3.9 U.K. carrier screening market, by end-user
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Target Disease Prevalence
8.3.4.3 Competitive Scenario
8.3.4.4 Regulatory Framework
8.3.4.5 Reimbursement Scenario
8.3.4.6 France carrier screening market, by type
8.3.4.7 France carrier screening market, by medical condition
8.3.4.8 France carrier screening market, by technology
8.3.4.9 France carrier screening market, by end-user
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Target Disease Prevalence
8.3.5.3 Competitive Scenario
8.3.5.4 Regulatory Framework
8.3.5.5 Reimbursement Scenario
8.3.5.6 Italy carrier screening market, by type
8.3.5.7 Italy carrier screening market, by medical condition
8.3.5.8 Italy carrier screening market, by technology
8.3.5.9 Italy carrier screening market, by end-user
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Target Disease Prevalence
8.3.6.3 Competitive Scenario
8.3.6.4 Regulatory Framework
8.3.6.5 Reimbursement Scenario
8.3.6.6 Spain carrier screening market, by type
8.3.6.7 Spain carrier screening market, by medical condition
8.3.6.8 Spain carrier screening market, by technology
8.3.6.9 Spain carrier screening market, by end-user
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Target Disease Prevalence
8.3.7.3 Competitive Scenario
8.3.7.4 Regulatory Framework
8.3.7.5 Reimbursement Scenario
8.3.7.6 Denmark carrier screening market, by type
8.3.7.7 Denmark carrier screening market, by medical condition
8.3.7.8 Denmark carrier screening market, by technology
8.3.7.9 Denmark carrier screening market, by end-user
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Target Disease Prevalence
8.3.8.3 Competitive Scenario
8.3.8.4 Regulatory Framework
8.3.8.5 Reimbursement Scenario
8.3.8.6 Sweden carrier screening market, by type
8.3.8.7 Sweden carrier screening market, by medical condition
8.3.8.8 Sweden carrier screening market, by technology
8.3.8.9 Sweden carrier screening market, by end-user
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Target Disease Prevalence
8.3.9.3 Competitive Scenario
8.3.9.4 Regulatory Framework
8.3.9.5 Reimbursement Scenario
8.3.9.6 Norway carrier screening market, by type
8.3.9.7 Norway carrier screening market, by medical condition
8.3.9.8 Norway carrier screening market, by technology
8.3.9.9 Norway carrier screening market, by end-user
8.4 Asia Pacific
8.4.1 SWOT Analysis
8.4.1.1 Asia Pacific carrier screening market, by type
8.4.1.2 Asia Pacific carrier screening market, by medical condition
8.4.1.3 Asia Pacific carrier screening market, by technology
8.4.1.4 Asia Pacific carrier screening market, by end-user
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Target Disease Prevalence
8.4.2.3 Competitive Scenario
8.4.2.4 Regulatory Framework
8.4.2.5 Reimbursement Scenario
8.4.2.6 Japan carrier screening market, by type
8.4.2.7 Japan carrier screening market, by medical condition
8.4.2.8 Japan carrier screening market, by technology
8.4.2.9 Japan carrier screening market, by end-user
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Target Disease Prevalence
8.4.3.3 Competitive Scenario
8.4.3.4 Regulatory Framework
8.4.3.5 Reimbursement Scenario
8.4.3.6 China carrier screening market, by type
8.4.3.7 China carrier screening market, by medical condition
8.4.3.8 China carrier screening market, by technology
8.4.3.9 China carrier screening market, by end-user
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Target Disease Prevalence
8.4.4.3 Competitive Scenario
8.4.4.4 Regulatory Framework
8.4.4.5 Reimbursement Scenario
8.4.4.6 India carrier screening market, by type
8.4.4.7 India carrier screening market, by medical condition
8.4.4.8 India carrier screening market, by technology
8.4.4.9 India carrier screening market, by end-user
8.4.5 South Korea
8.4.5.1 Key Country Dynamics
8.4.5.2 Target Disease Prevalence
8.4.5.3 Competitive Scenario
8.4.5.4 Regulatory Framework
8.4.5.5 Reimbursement Scenario
8.4.5.6 South Korea carrier screening market, by type
8.4.5.7 South Korea carrier screening market, by medical condition
8.4.5.8 South Korea carrier screening market, by technology
8.4.5.9 South Korea carrier screening market, by end-user
8.4.6 Australia
8.3.9.1 Key Country Dynamics
8.4.6.2 Target Disease Prevalence
8.4.6.3 Competitive Scenario
8.4.6.4 Regulatory Framework
8.4.6.5 Reimbursement Scenario
8.4.6.6 Australia carrier screening market, by type
8.4.6.7 Australia carrier screening market, by medical condition
8.4.6.8 Australia carrier screening market, by technology
8.4.6.9 Australia carrier screening market, by end-user
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Target Disease Prevalence
8.4.7.3 Competitive Scenario
8.4.7.4 Regulatory Framework
8.4.7.5 Reimbursement Scenario
8.4.7.6 Thailand carrier screening market, by type
8.4.7.7 Thailand carrier screening market, by medical condition
8.4.7.8 Thailand carrier screening market, by technology
8.4.7.9 Thailand carrier screening market, by end-user
8.5 Latin America
8.5.1 SWOT Analysis
8.5.1.1 Latin America carrier screening market, by type
8.5.1.2 Latin America carrier screening market, by medical condition
8.5.1.3 Latin America carrier screening market, by technology
8.5.1.4 Latin America carrier screening market, by end-user
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Target Disease Prevalence
8.5.2.3 Competitive Scenario
8.5.2.4 Regulatory Framework
8.5.2.5 Reimbursement Scenario
8.5.2.6 Brazil carrier screening market, by type
8.5.2.7 Brazil carrier screening market, by medical condition
8.5.2.8 Brazil carrier screening market, by technology
8.5.2.9 Brazil carrier screening market, by end-user
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Target Disease Prevalence
8.5.3.3 Competitive Scenario
8.5.3.4 Regulatory Framework
8.5.3.5 Reimbursement Scenario
8.5.3.6 Mexico carrier screening market, by type
8.5.3.7 Mexico carrier screening market, by medical condition
8.5.3.8 Mexico carrier screening market, by technology
8.5.3.9 Mexico carrier screening market, by end-user
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Target Disease Prevalence
8.5.4.3 Competitive Scenario
8.5.4.4 Regulatory Framework
8.5.4.5 Reimbursement Scenario
8.5.4.6 Argentina carrier screening market, by type
8.5.4.7 Argentina carrier screening market, by medical condition
8.5.4.8 Argentina carrier screening market, by technology
8.5.4.9 Argentina carrier screening market, by end-user
8.6 MEA
8.6.1 SWOT Analysis
8.6.1.1 MEA carrier screening market, by type
8.6.1.2 MEA carrier screening market, by medical condition
8.6.1.3 MEA carrier screening market, by technology
8.6.1.4 MEA carrier screening market, by end-user
8.6.2 South Africa
8.6.4.1 Key Country Dynamics
8.6.2.2 Target Disease Prevalence
8.6.2.3 Competitive Scenario
8.6.2.4 Regulatory Framework
8.6.2.5 Reimbursement Scenario
8.6.2.6 Argentina carrier screening market, by type
8.6.2.7 Argentina carrier screening market, by medical condition
8.6.2.8 Argentina carrier screening market, by technology
8.6.2.9 Argentina carrier screening market, by end-user
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Target Disease Prevalence
8.6.3.3 Competitive Scenario
8.6.3.4 Regulatory Framework
8.6.3.5 Reimbursement Scenario
8.6.3.6 Saudi Arabia carrier screening market, by type
8.6.3.7 Saudi Arabia carrier screening market, by medical condition
8.6.3.8 Saudi Arabia carrier screening market, by technology
8.6.3.9 Saudi Arabia carrier screening market, by end-user
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 Target Disease Prevalence
8.6.4.3 Competitive Scenario
8.6.4.4 Regulatory Framework
8.6.4.5 Reimbursement Scenario
8.6.4.6 UAE carrier screening market, by type
8.6.4.7 UAE carrier screening market, by medical condition
8.6.4.8 UAE carrier screening market, by technology
8.6.4.9 UAE carrier screening market, by end-user
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Target Disease Prevalence
8.6.5.3 Competitive Scenario
8.6.5.4 Regulatory Framework
8.6.5.5 Reimbursement Scenario
8.6.5.6 Kuwait carrier screening market, by type
8.6.5.7 Kuwait carrier screening market, by medical condition
8.6.5.8 Kuwait carrier screening market, by technology
8.6.5.9 Kuwait carrier screening market, by end-user
Chapter 9 Competitive Landscape
9.1 Participant’s overview
9.2 Financial performance
9.3 Participant categorization
9.3.1 Market leaders
9.3.1.1 Carrier screening market share analysis, 2022
9.3.1.2 Company profiles
9.3.1.2.1 Thermo Fisher Scientific Inc.
9.3.1.2.2 Myriad Genetics, Inc.
9.3.1.2.3 Cepheid
9.3.1.2.4 Laboratory Corporation of America Holdings
9.3.1.2.5 Otogenetics
9.3.1.2.6 Illumina Inc.
9.3.1.2.7 MedGenome
9.3.1.2.8 GeneTech
9.3.1.2.9 Centogene N.V.
9.3.1.2.10 F. Hoffman-La Roche Limited
9.3.2 Strategy mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Product/service launch
9.3.2.5 Partnerships
9.3.2.6 Others
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 4 Global Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 5 Global Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 6 Global Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 7 Global Carrier screening Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Carrier screening Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 10 North America Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 11 North America Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 12 North America Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 13 U.S. Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 14 U.S. Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 15 U.S. Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 16 U.S. Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 17 Canada Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 18 Canada Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 19 Canada Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 20 Canada Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 21 Europe Carrier screening Market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 23 Europe Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 24 Europe Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 25 Europe Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 26 Germany Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 27 Germany Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 28 Germany Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 29 Germany Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 30 U.K. Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 31 U.K. Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 32 U.K. Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 33 U.K. Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 34 France Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 35 France Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 36 France Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 37 France Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 38 Italy Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 39 Italy Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 40 Italy Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 41 Italy Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 42 Spain Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 43 Spain Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 44 Spain Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 45 Spain Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 46 Denmark Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 47 Denmark Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 48 Denmark Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 49 Denmark Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 50 Sweden Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 51 Sweden Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 52 Sweden Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 53 Sweden Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 54 Norway Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 55 Norway Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 56 Norway Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 57 Norway Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Carrier screening Market, by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 63 China Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 64 China Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 65 China Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 66 China Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 67 Japan Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 68 Japan Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 69 Japan Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 70 Japan Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 71 India Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 72 India Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 73 India Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 74 India Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 75 South Korea Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 76 South Korea Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 77 South Korea Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 78 South Korea Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 79 Australia Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 80 Australia Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 81 Australia Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 82 Australia Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 83 Thailand Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 84 Thailand Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 85 Thailand Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 86 Thailand Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 87 Latin America Carrier screening Market, by Country, 2018 - 2030 (USD Million)
Table 88 Latin America Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 89 Latin America Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 90 Latin America Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 91 Latin America Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 92 Brazil Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 93 Brazil Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 94 Brazil Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 95 Brazil Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 96 Mexico Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 97 Mexico Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 98 Mexico Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 99 Mexico Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 100 Argentina Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 101 Argentina Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 102 Argentina Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 103 Argentina Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Carrier screening Market, by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 109 South Africa Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 110 South Africa Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 111 South Africa Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 112 South Africa Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 117 UAE Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 118 UAE Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 119 UAE Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 120 UAE Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
Table 121 Kuwait Carrier screening Market, by Type, 2018 - 2030 (USD Million)
Table 122 Kuwait Carrier screening Market, by Medical conditions, 2018 - 2030 (USD Million)
Table 123 Kuwait Carrier screening Market, by Technology, 2018 - 2030 (USD Million)
Table 124 Kuwait Carrier screening Market, by End-user, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Carrier screening Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Carrier screening Market: Type Movement Analysis
Fig. 17 Global Carrier screening Market, for Expanded Carrier Screening, 2018 - 2030 (USD Million)
Fig. 18 Global Carrier screening Market, for Targeted Disease, 2018 - 2030 (USD Million)
Fig. 19 Global Carrier screening Market: Medical Condition Movement Analysis
Fig. 20 Global Carrier screening Market, for Cystic Fibrosis, 2018 - 2030 (USD Million)
Fig. 21 Global Carrier screening Market, for Tay-Sachs, 2018 - 2030 (USD Million)
Fig. 22 Global Carrier screening Market, for Gaucher Disease, 2018 - 2030 (USD Million)
Fig. 23 Global Carrier screening Market, for Sickle Cell Disease, 2018 - 2030 (USD Million)
Fig. 24 Global Carrier screening Market, for Spinal Muscular Atrophy, 2018 - 2030 (USD Million)
Fig. 25 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
Fig. 26 Global Carrier screening Market: Technology Movement Analysis
Fig. 27 Global Carrier screening Market, for DNA Sequencing, 2018 - 2030 (USD Million)
Fig. 28 Global Carrier screening Market, for Polymerase Chain Reaction, 2018 - 2030 (USD Million)
Fig. 29 Global Carrier screening Market, for Microarrays, 2018 - 2030 (USD Million)
Fig. 30 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
Fig. 31 Global Carrier screening Market: End User Movement Analysis
Fig. 32 Global Carrier screening Market, for Hospitals, 2018 - 2030 (USD Million)
Fig. 33 Global Carrier screening Market, for Laboratories, 2018 - 2030 (USD Million)
Fig. 34 Global Carrier screening Market, for Physician Offices & Clinics, 2018 - 2030 (USD Million)
Fig. 35 Global Carrier screening Market, for Other, 2018 - 2030 (USD Million)
Fig. 36 Regional Marketplace: Key Takeaways
Fig. 37 Regional Outlook, 2022 & 2030
Fig. 38 Global Carrier screening Market: Region Movement Analysis
Fig. 39 North America Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 40 U.S. Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 41 Canada Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 42 Europe Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 43 Germany Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 44 U.K. Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 45 France Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 46 Italy Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 47 Spain Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 48 Denmark Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 49 Sweden Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 50 Norway Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 52 Japan Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 53 China Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 54 India Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 55 Australia Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 56 South Korea Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 57 Thailand Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 58 Latin America Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 59 Brazil Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 60 Mexico Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 61 Argentina Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 62 Middle East and Africa Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 63 South Africa Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 64 Saudi Arabia Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 65 UAE Carrier screening Market, 2018 - 2030 (USD Million)
Fig. 66 Kuwait Carrier screening Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Myriad Genetics, Inc.
  • Cepheid
  • Laboratory Corporation of America Holdings
  • Otogenetics
  • Illumina Inc.
  • MedGenome
  • GeneTech
  • Centogene N.V.
  • F. Hoffman-La Roche Limited

Methodology

Loading
LOADING...